Taking Blood Thinners After a Stroke Does Not Improve Outcomes, Study Says

Translate to Spanish or other 102 languages!

Adding blood thinners to clot-busting medication after a stroke does not appear to improve the outcomes, according to a new study. Image for illustration purposes
Adding blood thinners to clot-busting medication after a stroke does not appear to improve the outcomes, according to a new study. Image for illustration purposes
- Advertisement -
  • About 15 million people around the world have a stroke each year, with about 62% of cases being ischemic strokes. 
  • The main treatment for ischemic stroke is a clot-busting medication delivered within 3 hours of having a stroke. 
  • After a stroke, a doctor may prescribe blood-thinning medications to help prevent clots from forming again. 
  • Researchers from the Washington University School of Medicine in St. Louis, MO, have found that giving blood thinners in conjunction with clot-busting medications when a person has an ischemic stroke did not improve the person’s 90-day outcome.

Researchers report that about 15 million people around the world have a stroke in the course of a year. About 62%Trusted Source of those people will have an ischemic stroke where blood flow to the brain is stopped due to arterial blockages.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/taking-blood-thinners-after-a-stroke-does-not-improve-outcomes-study-says?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-02-15&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS and Prominence Health Team Up on Medication Safety

 The Senior Living Seminar offered practical tips on managing prescriptions, avoiding harmful drug interactions and improving overall health outcomes.

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen on Oct. 16th

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

FDA Approves First Heart Valve Designed to Grow with Children

The U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.
- Advertisement -